Efficacy of Somatostatin Analogues (SSAs) in Patients with Neuroendocrine Tumors (NETs) According to the 2010 WHO Classification of NET: A Multicentric Study

#735

Introduction: SSAs have recently been demonstrated to have antiproliferative effects in ileal NETs. No data are available on SSA efficacy according to 2010 WHO NET categories.

Aim(s): To evaluate the efficacy of long-acting SSA in NET pts according to 2010 WHO classification.

Materials and methods: An observational Italian multicentric study has been designed to collect data on NET pts under treatment with SSA. The observational data have been collected through an e-CRF and data have been stored and processed in a centralized computer database. Both retrospective data of pts in treatment with SSA from 2005 and prospective data of pts treated with SSA from March 2012 to November 2012 were included.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Faggiano A, Tafuto S, Riccardi F, Tozzi L, Belfiore A,

Keywords: neuroendocrine tumor, Somatostatin Analogues, efficacy, WHO classification,